STOCK ALARM
PRO
SA
PRO
News
Screener
Alerts
Themes
Research
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Kaleido Biosciences, Inc.
KLDO
OTCMARKET
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$1M
↑13%
Gross Profit
$-1M
↑98%
Operating Income
$-88M
↓11%
Net Income
$-90M
↓11%
EBITDA
$-85M
↓11%
EPS Diluted
-2.2
Cost of Revenue
$2M
Gross Margin %
-113.6%
R&D Expenses
$68M
SG&A Expenses
$21M
Operating Expenses
$86M
Operating Margin %
-7940.9%
Interest Expense
$3M
Income Before Tax
$-90M
Income Tax Expense
$0
Net Margin %
-8178.3%
EPS
-2.2
Shares Out (Diluted)
41.9M
Shares Out (Basic)
41.9M
Total Costs & Expenses
$89M
Interest Income
$72K
EBITDA Margin %
-7707.6%
Pre-Tax Margin %
-8178.3%
Other Income/Expenses
$-3M
Revenue CAGR (5Y)
—
Margin Trend
improving
Free Cash Flow
($0.1B)
Profitability
Unprofitable
Metric
Dec 17
Dec 18
Dec 19
Dec 20
Dec 21
Revenue
0
0
0
1
1
↑13.2%
Gross Profit
0
0
-1
-55
↓4072.4%
-1
↑97.7%
Operating Income
-27
-61
↓124.5%
-87
↓42.8%
-79
↑9.0%
-88
↓11.1%
Net Income
-28
-62
↓124.0%
-85
↓37.7%
-82
↑4.0%
-90
↓10.6%
EBITDA
-27
-59
↓121.1%
-84
↓42.4%
-77
↑8.4%
-85
↓10.5%
EPS Diluted
-1.23
-2.10
↓70.7%
-3.31
↓57.6%
-2.44
↑26.3%
-2.16
↑11.5%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages